Ondine Biomedical Inc.
OBIMF
$0.25
$0.0847.06%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.20% | -35.64% | -3.73% | -8.06% | 2.57% |
| Total Depreciation and Amortization | -1.18% | -9.29% | 3.70% | 7.57% | -2.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.20% | 114.68% | 3.72% | -47.16% | -2.57% |
| Change in Net Operating Assets | -1.21% | 28.64% | 3.72% | -14.25% | -2.56% |
| Cash from Operations | 1.20% | -34.98% | -3.73% | -18.06% | 2.57% |
| Capital Expenditure | 1.18% | -288.51% | -3.57% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.18% | -288.51% | -3.57% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 0.00% |
| Total Debt Repaid | 0.00% | 25.69% | 0.00% | 70.54% | 0.00% |
| Issuance of Common Stock | 0.00% | 250.20% | 0.00% | -65.89% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -6,086.36% | 0.00% | 98.41% | 0.00% |
| Cash from Financing | -1.20% | 239.39% | 3.73% | -67.21% | -2.57% |
| Foreign Exchange rate Adjustments | -1.09% | -75.36% | 3.70% | -40.72% | -2.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.21% | 215.21% | -3.73% | -149.68% | -2.57% |